-
September 21: The Week in Cancer News
Patients weigh in on the impact of end-of-treatment bells in cancer centers, and a study suggests that current protocols for BRCA screening may miss testing some patients with mutations.
by Kate Yandell
-
September 14: The Week in Cancer News
An article sparks discussion about precision medicine hype, and a study tallies the rare fatal side effects of immune checkpoint inhibitors.
by Kate Yandell
-
September 7: The Week in Cancer News
A study quantifies gains in breast cancer survival in young women, and a cancer doctor reflects on her experience as a cancer patient.
by Kate Yandell
-
August 31: The Week in Cancer News
A study discusses the harms of breast cancer surgery for women in nursing homes, and an oncologist reflects on the use of military metaphors in writing about John McCain's cancer.
by Kate Yandell
-
August 24: The Week in Cancer News
Researchers investigate how often retailers sell cigarettes to minors, and a trial shows the benefits of immunotherapy for melanoma patients with brain metastases.
by Kate Yandell
-
August 17: The Week in Cancer News
Researchers suggest reclassification of low-risk cancers, and an immunotherapy drug is approved for small cell lung cancer.
by Kate Yandell
-
August 10: The Week in Cancer News
Organizations work to broaden eligibility for cancer clinical trials, and an article explores the limitations of personalized mouse models.
by Kate Yandell
-
August 3: The Week in Cancer News
A study indicates that being diagnosed with cancer as a child could lead to financial problems later, and the Trump administration relaxes restrictions on short-term health insurance policies.
by Kate Yandell
-
July 27: The Week in Cancer News
A study asks whether sunless tanning might encourage riskier tanning behavior, and an article investigates the supercomputer Watson's performance.
by Kate Yandell
-
July 20: The Week in Cancer News
A Chinese movie prompts political discourse about the cost of medication, and a study suggests that dining and sleeping habits may contribute to a person's risk of breast and prostate cancer.
by Brad Jones
Cancer Talk
Designing Clinical Trials for the Patient
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose